WebThe Federal Institute for Drugs and Medical Devices (in German: Bundesinstitut für Arzneimittel und Medizinprodukte – BfArM) is the medical regulatory body in Germany. … WebMay 13, 2024 · Immunic, Inc. Receives First Regulatory Approval from German Health Authority BfArM to Initiate a Phase 2 Clinical Trial of its Selective Oral DHODH …
Federal Institute for Drugs and Medical Devices - CrunchBase
WebAddress for application BfArM: Bundesinstitut für Arzneimittel und Medizinprodukte Fachregistratur Klinische Prüfung von Arzneimitteln Kurt-Georg-Kiesinger-Allee 3 53175 … WebAbout us. The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) is an independent federal higher authority within the portfolio of the Federal Ministry of Health. At the BfArM, roughly 1,350 employees (physicians, pharmacists, chemists, biologists, lawyers, engineers, technical assistants, … ofw returning to uae requirements 2022
Federal Institute for Drugs and Medical Devices: Global Health ...
WebHealth knows no national borders. That is why experts work together internationally in the authorisation and monitoring of quality, efficacy and safety of medicinal products. The … WebFederal Institute for Drugs and Medical Devices The BfArMis a Federal Institute within the portfolio of the Federal Ministry of Health (Germany) • Sponsors wish short review times for phase I trial • BfArM observes increased complexity of phase I protocols over the last years WebJun 9, 2024 · CALVID-1 received regulatory allowance from the German health authority, BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte), on May 13, 2024 and has subsequently also received regulatory allowance in other European countries involved in the study. It is a prospective, multicenter, randomized, placebo-controlled, double-blind … ofw returning to philippines from malaysia